{"id":931,"date":"2024-08-06T14:03:41","date_gmt":"2024-08-06T14:03:41","guid":{"rendered":"https:\/\/euprtoday.com\/valneva-feu-vert-de-lue-a-la-commercialisation-du-vaccin-contre-le-chikungunya\/"},"modified":"2024-08-06T14:03:41","modified_gmt":"2024-08-06T14:03:41","slug":"valneva-feu-vert-de-lue-a-la-commercialisation-du-vaccin-contre-le-chikungunya","status":"publish","type":"post","link":"https:\/\/euprtoday.com\/fr\/valneva-feu-vert-de-lue-a-la-commercialisation-du-vaccin-contre-le-chikungunya\/","title":{"rendered":"Valneva-Feu vert de l&rsquo;UE \u00e0 la commercialisation du vaccin contre le chikungunya"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p>PARIS, 1er juillet (Reuters) &#8211; Valneva a annonc\u00e9 lundi avoir re\u00e7u une autorisation de la part de la Commission europ\u00e9enne pour la mise sur le march\u00e9 de IXCHIQ, son vaccin \u00e0 dose unique pour la pr\u00e9vention de la maladie caus\u00e9e par le virus du chikungunya.<\/p>\n<p>Le virus du chikungunya (CHIKV) est une maladie transmise par des piq\u00fbres de moustiques infect\u00e9s.<\/p>\n<p>\u00ab\u00a0Ixchiq est le seul vaccin approuv\u00e9 contre le chikungunya dans le monde, permettant ainsi de proposer une r\u00e9ponse \u00e0 ce besoin m\u00e9dical non satisfait\u00a0\u00bb, d\u00e9clare le laboratoire m\u00e9dical fran\u00e7ais dans un communiqu\u00e9.<\/p>\n<p>Le vaccin a d\u00e9j\u00e0&#8230;<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/investir.lesechos.fr\/actu-des-valeurs\/la-vie-des-actions\/valneva-feu-vert-de-lue-a-la-commercialisation-du-vaccin-contre-le-chikungunya-2104903\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PARIS, 1er juillet (Reuters) &#8211; Valneva a annonc\u00e9 lundi avoir re\u00e7u une autorisation de la part de la Commission europ\u00e9enne pour la mise sur le march\u00e9 de IXCHIQ, son vaccin \u00e0 dose unique pour la pr\u00e9vention de la maladie caus\u00e9e par le virus du chikungunya. Le virus du chikungunya (CHIKV) est une maladie transmise par [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":{"0":"post-931","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-marketing"},"_links":{"self":[{"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/posts\/931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/comments?post=931"}],"version-history":[{"count":0,"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/posts\/931\/revisions"}],"wp:attachment":[{"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/media?parent=931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/categories?post=931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/euprtoday.com\/fr\/wp-json\/wp\/v2\/tags?post=931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}